Coumarin derivative and use thereof
    1.
    发明授权
    Coumarin derivative and use thereof 失效
    香豆素衍生物及其用途

    公开(公告)号:US07541478B2

    公开(公告)日:2009-06-02

    申请号:US10591561

    申请日:2005-03-01

    IPC分类号: C07D311/02

    CPC分类号: C07D311/16

    摘要: The present invention relates to an alkaline earth metal salt or an organic amine salt of a compound represented by the formula [I]: wherein R1 and R2 are each a hydrogen atom, a halogen atom, or an optionally substituted linear hydrocarbon group; ring A is an optionally further substituted benzene ring; B is an optionally substituted benzene ring; R is a carboxyl group or a linear hydrocarbon group substituted with a carboxyl group and the like.

    摘要翻译: 本发明涉及由式[I]表示的化合物的碱土金属盐或有机胺盐:其中R1和R2各自为氢原子,卤素原子或任选取代的直链烃基; 环A是任选进一步取代的苯环; B是任选取代的苯环; R是羧基或被羧基等取代的直链烃基。

    Coumarin Derivative And Use Thereof
    2.
    发明申请
    Coumarin Derivative And Use Thereof 失效
    香豆素衍生物及其用途

    公开(公告)号:US20070197636A1

    公开(公告)日:2007-08-23

    申请号:US10591561

    申请日:2005-03-01

    IPC分类号: A61K31/366 C07D311/02

    CPC分类号: C07D311/16

    摘要: The present invention relates to an alkaline earth metal salt or an organic amine salt of a compound represented by the formula : wherein R1 and R2 are each a hydrogen atom, a halogen atom, or an optionally substituted linear hydrocarbon group; ring A is an optionally further substituted benzene ring; B is an optionally substituted benzene ring; R is a carboxyl group or a linear hydrocarbon group substituted with a carboxyl group and the like.

    摘要翻译: 本发明涉及由下式表示的化合物的碱土金属盐或有机胺盐:其中R 1和R 2各自为氢原子, 卤素原子或任选取代的直链烃基; 环A是任选进一步取代的苯环; B是任选取代的苯环; R是羧基或被羧基等取代的直链烃基。

    Coumarin derivatives, process for their production and use thereof
    3.
    发明申请
    Coumarin derivatives, process for their production and use thereof 审中-公开
    香豆素衍生物,其生产和使用的方法

    公开(公告)号:US20070179154A1

    公开(公告)日:2007-08-02

    申请号:US11728550

    申请日:2007-03-26

    IPC分类号: A61K31/496 C07D405/02

    摘要: Compounds represented by the general formula [I]: wherein R1 and R2 are each hydrogen, halogen, an optionally substituted linear hydrocarbon group, or hydroxyl which may be substituted with an optionally substituted liner hydrocarbon group, or R1 and R2 together with the carbon atoms adjacent thereto may form an optionally substituted cyclic hydrocarbon or a dihydrofuran ring which may have an oxo group; ring A is a benzene ring which may be further substituted; ring B is an aromatic ring which may be substituted; X is a bond or a spacer whose main chain has 1 to 6 atoms; Y is carboxyl which may be esterified, carbamoyl which may be substituted, cyano, or an optionally substituted heterocyclic group bearing a hydrogen atom capable of being deprotonated, or salts thereof, which are useful as lipid-rich plaque regressing agents and/or ACAT inhibitors.

    摘要翻译: 由通式[I]表示的化合物:其中R 1和R 2各自为氢,卤素,任选取代的直链烃基或可以被 任选取代的环状烃基或R 1和R 2与其相邻的碳原子一起可以形成任选取代的环烃或二氢呋喃环,其可以具有氧代 组; 环A是可以被进一步取代的苯环; 环B是可被取代的芳环; X是主链具有1至6个原子的键或间隔基; Y是可以被酯化的羧基,可以被取代的氨基甲酰基,氰基或具有能够被去质子化的氢原子的任选取代的杂环基或其盐,其可用作富脂质斑块回归剂和/或ACAT抑制剂 。

    Naphtholactams and lactones as bone morphogenetic protein active agents
    5.
    发明授权
    Naphtholactams and lactones as bone morphogenetic protein active agents 失效
    萘酚内酯和内酯作为骨形态发生蛋白活性剂

    公开(公告)号:US6030967A

    公开(公告)日:2000-02-29

    申请号:US945631

    申请日:1997-10-30

    摘要: A compound of the formula: whereinQ is an optionally substituted carbon atom or N(O)p wherein p is 0 or 1;Y is an optionally substituted methylene group, S(O)q wherein q is an integer of 0 to 2, or an optionally substituted imino group;Z.sup.1 is a C.sub.1-3 alkylene group which may have an oxo group or a thioxo group and may contain etherified oxygen or sulfur within the carbon chain;Z.sup.2 is an optionally substituted C.sub.1-3 alkylene group;Ar is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;one of R.sup.1 and R.sup.2 is a hydrogen atom, a halogen atom, a hydroxyl group, an optionally substituted lower alkyl group, or an optionally substituted lower alkoxy group;the other is a halogen atom, a hydroxyl group, an optionally substituted lower alkyl group, or an optionally substituted lower alkoxy group; orR.sup.1 and R.sup.2 taken together with adjacent --c.dbd.c-- form a ring; andring A is a benzene ring which may be substituted in addition to R.sup.1 and R.sup.2 ; or a salt thereof.

    摘要翻译: PCT No.PCT / JP97 / 02858 Sec。 371 1997年10月30日第 102(e)1997年10月30日PCT PCT 1997年8月19日PCT公布。 第WO98 / 07705号公报 日期:1998年2月26日一种下式的化合物:其中Q是任选取代的碳原子或N(O)p,其中p是0或1; Y是任选取代的亚甲基,S(O)q,其中q是0-2的整数,或任选取代的亚氨基; Z1是可以具有氧代基或硫代基的C1-3亚烷基,并且可以在碳链内含有醚化的氧或硫; Z2是任选取代的C 1-3亚烷基; Ar是任选取代的碳环基团或任选取代的杂环基团; R 1和R 2中的一个是氢原子,卤素原子,羟基,任选取代的低级烷基或任选取代的低级烷氧基; 另一个是卤素原子,羟基,任意取代的低级烷基或任意取代的低级烷氧基; 或者R 1和R 2与相邻的-c = c-一起形成环; 环A是除R1和R2之外可以被取代的苯环; 或其盐。

    Fused heterocyclic compounds
    8.
    发明授权
    Fused heterocyclic compounds 失效
    稠合杂环化合物

    公开(公告)号:US07034039B2

    公开(公告)日:2006-04-25

    申请号:US10470805

    申请日:2002-02-01

    IPC分类号: C07D217/02 A61K31/47

    摘要: The present invention provides a compound of the formula: wherein ring A is an optionally substituted 5 to 10-membered aromatic ring; R1 and R2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X is a bond and the like; and L is a divalent hydrocarbon group, and a salt thereof, except 3-(aminomethyl)-2,6,7-trimethyl-4-phenyl-1(2H)-isoquinolinone, 3-(aminomethyl)-2-methyl-4-phenyl-1(2H)-isoquinolinone, 3-(aminomethyl)-6-chloro-2-methyl-4-phenyl-1(2H)-isoquinolinone and 3-(aminomethyl)-2-isopropyl-4-phenyl-1(2H)-isoquinolinone. The compound shows a superior peptidase-inhibitory activity and is useful as an agent for the prophylaxis or treatment of diabetes and the like.

    摘要翻译: 本发明提供下式的化合物:其中环A是任选取代的5至10元芳环; R 1和R 2相同或不同,并且各自为任选取代的烃基或任选取代的杂环基; X是一个键等; 和L是二价烃基及其盐,除了3-(氨基甲基)-2,6,7-三甲基-4-苯基-1(2H) - 异喹啉酮,3-(氨基甲基)-2-甲基-4 - 苯基-1(2H) - 异喹啉酮,3-(氨基甲基)-6-氯-2-甲基-4-苯基-1(2H) - 异喹啉酮和3-(氨基甲基)-2-异丙基-4-苯基-1 (2H) - 异喹啉酮。 该化合物显示出优异的肽酶抑制活性,并且可用作预防或治疗糖尿病等的药剂。